Please provide your email address to receive an email when new articles are posted on . Fewer than 6% were “early switchers,” despite this being associated with a shorter duration of antibiotics and ...

Please provide your email address to receive an email when new articles are posted on . Oral antibiotics may be noninferior to IV antibiotics for treatment of fracture-related infection. The ...

Credit: Getty Images. Ceftobiprole is a broad spectrum cephalosporin antibiotic. The Food and Drug Administration (FDA) has accepted the New Drug Application for ceftobiprole, an investigational, ...

Due to rising antimicrobial resistance, the treatment of complicated UTIs and acute pyelonephritis is becoming more difficult ...

Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of oral tebipenem HBr ...

Under the terms of a deal that rescued the once-rejected tebipenem HBr, GSK will file for approval of the oral antibiotic. Back in 2022, after the FDA requested another phase 3 trial and denied ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window An early switch to oral antibiotics in patients hospitalized ...

A new report from the Centers for Disease Control and Prevention on the deadly drug-resistant bacteria NDM-CRE found a 70% ...

A scoping review reveals non-sterile glove use during IV antibiotic preparation lacks evidence, potentially harming infection ...

Punjab health minister said a committee has been formed and action will be taken against the suppliers based on the report ...